Publicaciones en las que colabora con CRISTINA ALONSO MONTES (30)

2024

  1. Novel Biomarkers of Bone Metabolism

    Nutrients, Vol. 16, Núm. 5

  2. Serum phosphate is associated with increased risk of bone fragility fractures in haemodialysis patients

    Nephrology Dialysis Transplantation, Vol. 39, Núm. 4, pp. 618-626

  3. Soluble Klotho, a Potential Biomarker of Chronic Kidney Disease–Mineral Bone Disorders Involved in Healthy Ageing: Lights and Shadows

    International Journal of Molecular Sciences, Vol. 25, Núm. 3

2023

  1. Effects of a Losartan-Antioxidant Hybrid (GGN1231) on Vascular and Cardiac Health in an Experimental Model of Chronic Renal Failure

    Nutrients, Vol. 15, Núm. 8

  2. Experimental Models to Study Diabetes Mellitus and Its Complications: Limitations and New Opportunities

    International Journal of Molecular Sciences, Vol. 24, Núm. 12

  3. MicroRNA-145 and microRNA-486 are potential serum biomarkers for vascular calcification

    Nephrology Dialysis Transplantation, Vol. 38, Núm. 7, pp. 1729-1740

  4. Mineral and bone metabolism markers and mortality in diabetic patients on haemodialysis

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, Vol. 38, Núm. 11, pp. 2589-2597

  5. Phosphorus May Induce Phenotypic Transdifferentiation of Vascular Smooth Muscle Cells through the Reduction of microRNA-145

    Nutrients, Vol. 15, Núm. 13

  6. Redox Metabolism and Vascular Calcification in Chronic Kidney Disease

    Biomolecules, Vol. 13, Núm. 9

  7. Role of Klotho and AGE/RAGE-Wnt/β-Catenin Signalling Pathway on the Development of Cardiac and Renal Fibrosis in Diabetes

    International journal of molecular sciences, Vol. 24, Núm. 6

  8. Serum and Urinary Soluble α-Klotho as Markers of Kidney and Vascular Impairment

    Nutrients, Vol. 15, Núm. 6

2021

  1. Chronic Kidney Disease—Mineral and Bone Disorders: Pathogenesis and Management

    Calcified Tissue International, Vol. 108, Núm. 4, pp. 410-422

  2. Effects of calcitriol and paricalcitol on renal fibrosis in CKD

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, Vol. 36, Núm. 5, pp. 793-803

  3. Fibrosis in chronic kidney disease: Pathogenesis and consequences

    International Journal of Molecular Sciences, Vol. 22, Núm. 1, pp. 1-19

  4. The receptor activator of nuclear factor κΒ ligand receptor leucine-rich repeat-containing G-protein-coupled receptor 4 contributes to parathyroid hormone-induced vascular calcification

    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, Vol. 36, Núm. 4, pp. 618-631

2020

  1. Impact of vascular calcification on bone health and mortality in kidney transplant patients

    Revista de Osteoporosis y Metabolismo Mineral, Vol. 12, Núm. 2, pp. 53-61

2019

  1. High-serum phosphate and parathyroid hormone distinctly regulate bone loss and vascular calcification in experimental chronic kidney disease

    Nephrology Dialysis Transplantation, Vol. 34, Núm. 6, pp. 934-941

2018

  1. Variants in cardiac GATA genes associated with bicuspid aortic valve

    European Journal of Clinical Investigation, Vol. 48, Núm. 12

2017

  1. Rare genetic variants in GATA transcription factors in patients with hypertrophic cardiomyopathy

    Journal of Investigative Medicine, Vol. 65, Núm. 5, pp. 926-934

2016

  1. Direct inhibition of osteoblastic Wnt pathway by fibroblast growth factor 23 contributes to bone loss in chronic kidney disease

    Kidney International, Vol. 90, Núm. 1, pp. 77-89